Acinar cell reprogramming: a clinically important target in pancreatic disease.
about
β-cell replacement sources for type 1 diabetes: a focus on pancreatic ductal cellsPeroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerSilencing Mist1 Gene Expression Is Essential for Recovery from Acute PancreatitisETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis.Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment.
P2860
Acinar cell reprogramming: a clinically important target in pancreatic disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Acinar cell reprogramming: a clinically important target in pancreatic disease.
@en
type
label
Acinar cell reprogramming: a clinically important target in pancreatic disease.
@en
prefLabel
Acinar cell reprogramming: a clinically important target in pancreatic disease.
@en
P2860
P356
P1433
P1476
Acinar cell reprogramming: a clinically important target in pancreatic disease.
@en
P2093
Joanna F Ryan
Rashid Mehmood
P2860
P304
P356
10.2217/EPI.14.83
P577
2015-01-01T00:00:00Z